Combining gemcitabine with checkpoint kinase inhibitors to sensitize pancreatic tumors
Main Author: | Saini, Priyanka |
---|---|
Other Authors: | Dobbelstein, Matthias Prof. Dr. |
Format: | Doctoral Thesis |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | http://hdl.handle.net/11858/00-1735-0000-0022-5FB7-B http://nbn-resolving.de/urn:nbn:de:gbv:7-11858/00-1735-0000-0022-5FB7-B-8 |
Similar Items
-
Targeting MDM2, the antagonist of the tumor suppressor p53
by: Sriraman, Anusha
Published: (2018) -
Targeting the Checkpoint to Kill Cancer Cells
by: Jan Benada, et al.
Published: (2015-08-01) -
Gemcitabine Resistance Elicits a Calcium Dependent Epigenetic Reprogramming in Pancreatic Cancer
by: Kutschat, Ana Patricia
Published: (2021) -
Harnessing DNA Replication Stress for Novel Cancer Therapy
by: Huanbo Zhu, et al.
Published: (2020-08-01) -
When heat casts a spell on the DNA damage checkpoints
by: Thomas Turner, et al.
Published: (2014-01-01)